A protein transduction method using oligo-arginine (3R) for the delivery of transcription factors into cell nuclei

Biomaterials

Volumn 33, Issue 18, 2012, Pages 4665-4672

  Hitsuda, Takashi ^a   Michiue, Hiroyuki ^a   Kitamatsu, Mizuki ^b   Fujimura, Atsushi ^a   Wang, Feifei ^a   Yamamoto, Takahiro ^b   Han, Xiao Jian ^a   Tazawa, Hiroshi ^a,c   Uneda, Atsuhito ^a   Ohmori, Iori ^a   Nishiki, Tei ichi ^a   Tomizawa, Kazuhito ^d   Matsui, Hideki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Arginine; Drug delivery; EGFP; P53; Protein transduction; TAT

Indexed keywords

ARGININE RESIDUE; BIOLOGICALLY ACTIVE COMPOUNDS; CANCER CELLS; CELL NUCLEUS; CELL-PENETRATING PEPTIDE; CULTURED CELL; EGFP; ENHANCED GREEN FLUORESCENCE PROTEINS; GLIOMA CELLS; HIV TAT; HYDROPHOBIC MOIETIES; OLIGOPEPTIDES; P53; PROTEIN TRANSDUCTION; TAT; TRANSCRIPTIONAL ACTIVITY;

BACTERIOPHAGES; BIOACTIVITY; CELLS; CYTOLOGY; DRUG DELIVERY; PEPTIDES; TRANSCRIPTION FACTORS; TUMORS;

ARGININE;

ARGININE; GREEN FLUORESCENT PROTEIN; PROTEIN P53; PYRENEBUTYRATE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CULTURE; CELL GROWTH; CELL NUCLEUS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GLIOMA CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSDUCTION; TRANSCRIPTION INITIATION;

CELL LINE; CELL NUCLEUS; DRUG DELIVERY SYSTEMS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; PEPTIDES; PROTEINS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION FACTORS; TRANSDUCTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84859875629     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.02.049     Document Type: Article

References (30)

1. Prochiantz A Messenger proteins: homeoproteins, TAT and others Curr Opin Cell Biol 2000, 12:400-406.
2. Vives E Cellular uptake [correction of utake] of the Tat peptide: an endocytosis mechanism following ionic interactions J Mol Recognit 2003, 16:265-271.
3. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F In vivo protein transduction: delivery of a biologically active protein into the mouse Science 1999, 285(5433):1569-1572.
4. Wadia J.S., Dowdy S.F Protein transduction technology Curr Opin Biotechnol 2002, 13(1):52-56.
5. Eguchi A., Meade B.R., Chang Y.C., Fredrickson C.T., Willert K., Puri N Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein Nat Biotechnol 2009, 27(6):567-571.
6. Michiue H., Eguchi A., Scadeng M., Dowdy S.F Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma Cancer Biol Ther 2009, 23:2306-2313.
7. Vivès E., Brodin P., Lebleu B A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J Biol Chem 1997, 272(25):16010-16017.
8. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., Sugiur Y Possible existence of common internalization mechanisms among arginine-rich peptides J Biol Chem 2002, 277(4):2437-2443.
9. Matsui H., Tomizawa K., Lu Y.F., Matsushita M Protein therapy: in vivo protein transduction by polyarginine (11R) PTD and subcellular targeting delivery Curr Protein Pept Sci 2003, 4:151-157.
10. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K Stearylated arginine-rich peptides: a new class of transfection systems Bioconjug Chem 2001, 12(6):1005-1011.
11. Matsushita M., Tomizawa K., Moriwaki M., Li S.H., Terada H., Ohmoto T A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation J Neurosci 2001, 21:6000-6007.
12. Tomizawa K., Sunada S., Lu Y.F., Oda Y., Kinuta M., Ohshima T Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles J Cell Biol 2003, 163(4):813-824.
13. Michiue H., Tomizawa K., Wei F.Y., Matsushita M., Lu Y.F., Ichikawa T The NH2 terminus of influenza virus hemagglutinin-2 subunit peptides enhances the antitumor potency of polyarginine-mediated p53 protein transduction J Biol Chem 2005, 280(9):8285-8289.
14. Takenobu T., Tomizawa K., Matsushita M., Li S.T., Moriwaki A., Lu Y.F Development of p53 protein transduction therapy using membrane-permeable peptides and the application to oral cancer cells Mol Cancer Ther 2002, 12:1043-1049.
15. Ozaki T., Nakagawara A p53: the attractive tumor suppressor in the cancer research field J Biomed Biotechnol 2011, 2011:603925.
16. Datto M.B., Yu Y., Wang X.F Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter J Biol Chem 1995, 270(48):28623-28628.
17. Kitamatsu M., Kashiwagi T., Sisido M Synthesis of a newly peptide nucleic acid that contains tertiary amino groups Nucleic Acids Symp Ser (Oxf) 2005, (49):363-364.
18. Takeuchi T., Kosuge M., Tadokoro A., Sugiura Y., Nishi M., Kawata M Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans Bioconjug Chem 2008, 19(3):656-664.
19. Michiue H., Tomizawa K., Matsushita M., Tamiya T., Lu Y.F., Ichikawa T Ubiquitination-resistant p53 protein transduction therapy facilitates anti-cancer effect on the growth of human malignant glioma cells FEBS Lett 2005, 579(18):3965-3969.
20. Wadia J.S., Stan R.V., Dowdy S.F Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat Med 2004, 10(3):310-315.
21. Matsushita M., Noguchi H., Lu Y.F., Tomizawa K., Michiue H., Li S.T Photo-acceleration of protein release from endosome in the protein transduction system FEBS Lett 2004, 572(1-3):221-226.
22. Wadia J.S., Dowdy S.F Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer Adv Drug Deliv Rev 2005, 57(4):579-596.
23. Michael D., Oren M The p53-Mdm2 module and the ubiquitin system Semin Cancer Biol 2003, 13(1):49-58.
24. Rodriguez M.S., Desterro J.M., Lain S., Lane D.P., Hay R.T Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation Mol Cell Biol 2000, 20(22):8458-8467.
25. Fittipaldi A., Giacca M Transcellular protein transduction using the Tat protein of HIV-1 Adv Drug Deliv Rev 2005, 57(4):597-608.
26. Jablonski A.E., Kawakami T., Ting A.Y., Payne C.K Pyrenebutyrate leads to cellular binding, not intracellular delivery, of polyarginine-quantum dots J Phys Chem Lett 2010, 1:1312-1315.
27. June R.K., Gogoi K., Eguchi A., Cui X.S., Dowdy S.F Synthesis of a pH-sensitive nitrilotriacetic linker to peptide transduction domains to enable intracellular delivery of histidine imidazole ring-containing macromolecules J Am Chem Soc 2010, 132(31):10680-10682.
28. Panwar M., Samarth R., Kumar M., Yoon W.J., Kumar A Inhibition of benzo(a)pyrene induced lung adenoma by panax ginseng extract, EFLA400, in Swiss albino mice Biol Pharm Bull 2005, (11):2063-2067.
29. Guterstam P., Madani F., Hirose H., Takeuchi T., Futaki S., El Andaloussi S Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate Biochim Biophys Acta 2009, 1788(12):2509-2517.
30. Matsushita M., Tomizawa K., Moriwaki A., Li S.T., Terada H., Matsui H A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation J Neurosci 2001, 21(16):6000-6007.